Annual Report 2024 Active Biotech AB (publ)

REG

Active Biotech (NASDAQ Stockholm:ACTI) announces today that the Annual Report 2024 now is available for download at www.activebiotech.com.

The Annual Report will only be digitally distributed.

“In the past year, we made significant progress in our clinical projects. For 2025, we will focus on advancing the ongoing clinical studies in myelofibrosis. Additionally, we are awaiting results from both the clinical study with tasquinimod in multiple myeloma and the biodistribution study with laquinimod,” says Active Biotech CEO Helén Tuvesson.

Datum 2025-04-07, kl 11:00
Källa MFN
Bifogade filer
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.